Literature DB >> 19329634

Genomic islands of uropathogenic Escherichia coli contribute to virulence.

Amanda L Lloyd1, Tiffany A Henderson, Patrick D Vigil, Harry L T Mobley.   

Abstract

Uropathogenic Escherichia coli (UPEC) strain CFT073 contains 13 large genomic islands ranging in size from 32 kb to 123 kb. Eleven of these genomic islands were individually deleted from the genome, and nine isogenic mutants were tested for their ability to colonize the CBA/J mouse model of ascending urinary tract infection. Three genomic island mutants (Delta PAI-aspV, Delta PAI-metV, and Delta PAI-asnT) were significantly outcompeted by wild-type CFT073 in the bladders and/or kidneys following transurethral cochallenge (P <or= 0.0139). The PAI-metV mutant also showed significant attenuation in the ability to independently colonize the kidneys (P = 0.0011). Specific genes within these islands contributed to the observed phenotype, including a previously uncharacterized iron acquisition cluster, fbpABCD (c0294 to c0297 [c0294-97]), autotransporter, picU (c0350), and RTX family exoprotein, tosA (c0363) in the PAI-aspV island. The double deletion mutant with deletions in both copies of the fbp iron acquisition operon (Deltac0294-97 Delta c2518-15) was significantly outcompeted by wild-type CFT073 in cochallenge. Strains with mutations in a type VI secretion system within the PAI-metV island did not show attenuation. The attenuation of the PAI-metV island was localized to genes c3405-10, encoding a putative phosphotransferase transport system, which is common to UPEC and avian pathogenic E. coli strains but absent from E. coli K-12. We have shown that, in addition to encoding virulence genes, genomic islands contribute to the overall fitness of UPEC strain CFT073 in vivo.

Entities:  

Mesh:

Year:  2009        PMID: 19329634      PMCID: PMC2681901          DOI: 10.1128/JB.01717-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  77 in total

1.  Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis.

Authors:  Ganwu Li; Claudia Laturnus; Christa Ewers; Lothar H Wieler
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Contact-dependent inhibition of growth in Escherichia coli.

Authors:  Stephanie K Aoki; Rupinderjit Pamma; Aaron D Hernday; Jessica E Bickham; Bruce A Braaten; David A Low
Journal:  Science       Date:  2005-08-19       Impact factor: 47.728

3.  Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system.

Authors:  Stefan Pukatzki; Amy T Ma; Derek Sturtevant; Bryan Krastins; David Sarracino; William C Nelson; John F Heidelberg; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Type-specific contributions to chromosome size differences in Escherichia coli.

Authors:  C K Rode; L J Melkerson-Watson; A T Johnson; C A Bloch
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Enteroaggregative Escherichia coli isolated from Chinese diarrhea patients with high-pathogenicity island of Yersinia is involved in synthesis of siderophore yersiniabactin.

Authors:  Jing Hu; Biao Kan; Zhi-Hua Liu; Shou-Yi Yu
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

6.  Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis.

Authors:  Kylie E Rodriguez-Siek; Catherine W Giddings; Curt Doetkott; Timothy J Johnson; Mohamed K Fakhr; Lisa K Nolan
Journal:  Microbiology       Date:  2005-06       Impact factor: 2.777

7.  Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Escherichia coli.

Authors:  Nick J Parham; Samantha J Pollard; Roy R Chaudhuri; Scott A Beatson; Mickaël Desvaux; Michael A Russell; Joaquim Ruiz; Amanda Fivian; Jordi Vila; Ian R Henderson
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

8.  Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and Catheter-associated bacteriuria and from fecal samples.

Authors:  D M Guyer; J S Kao; H L Mobley
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  The high-pathogenicity island of Yersinia pseudotuberculosis can be inserted into any of the three chromosomal asn tRNA genes.

Authors:  C Buchrieser; R Brosch; S Bach; A Guiyoule; E Carniel
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

10.  Identification of S, F1C and three PapG fimbrial adhesins in uropathogenic Escherichia coli by polymerase chain reaction.

Authors:  K Mitsumori; A Terai; S Yamamoto; O Yoshida
Journal:  FEMS Immunol Med Microbiol       Date:  1998-08
View more
  59 in total

1.  Identification of Escherichia coli genes associated with urinary tract infections.

Authors:  Bin-Hsu Mao; Yung-Fu Chang; Joy Scaria; Chih-Ching Chang; Li-Wei Chou; Ni Tien; Jiunn-Jong Wu; Chin-Chung Tseng; Ming-Cheng Wang; Chao-Chin Chang; Yuan-Man Hsu; Ching-Hao Teng
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  The influence of the accessory genome on bacterial pathogen evolution.

Authors:  Robert W Jackson; Boris Vinatzer; Dawn L Arnold; Steve Dorus; Jesús Murillo
Journal:  Mob Genet Elements       Date:  2011-05

4.  Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation.

Authors:  Viktoria Hancock; Rebecca Munk Vejborg; Per Klemm
Journal:  Mol Genet Genomics       Date:  2010-10-01       Impact factor: 3.291

5.  A unique arabinose 5-phosphate isomerase found within a genomic island associated with the uropathogenicity of Escherichia coli CFT073.

Authors:  Joshua A Mosberg; Alejandra Yep; Timothy C Meredith; Sara Smith; Pan-Fen Wang; Tod P Holler; Harry L T Mobley; Ronald W Woodard
Journal:  J Bacteriol       Date:  2011-04-15       Impact factor: 3.490

Review 6.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

7.  Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Authors:  Patrick D Vigil; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

8.  Epigenetic Mechanisms Regulate Innate Immunity against Uropathogenic and Commensal-Like Escherichia coli in the Surrogate Insect Model Galleria mellonella.

Authors:  Miriam Heitmueller; André Billion; Ulrich Dobrindt; Andreas Vilcinskas; Krishnendu Mukherjee
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

9.  A conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility.

Authors:  Michael D Engstrom; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2014-06-16       Impact factor: 3.441

10.  Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82.

Authors:  Sylvie Miquel; Eric Peyretaillade; Laurent Claret; Amélie de Vallée; Carole Dossat; Benoit Vacherie; El Hajji Zineb; Beatrice Segurens; Valerie Barbe; Pierre Sauvanet; Christel Neut; Jean-Frédéric Colombel; Claudine Medigue; Francisco J M Mojica; Pierre Peyret; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.